Undetected Anal and Anorectal Tumors in Endoscopic Assessments: A Retrospective Analysis Over Ten Years
-
By
-
Zhu-Jun Wu
-
Hui Gong
-
Ya-Xin Li
-
Yuan Li
-
Wei-Yi Wu
-
Lin-Jie Guo
-
February 6, 2026
-
Clinical Scorecard: Undetected Anal and Anorectal Tumors in Endoscopic Assessments: A Retrospective Analysis Over Ten Years
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Patients histopathologically diagnosed with anal and anorectal tumors within the last 10 years. |
| Care Setting | |
Key Highlights
- IMPROVE detection strategy includes identifying high-risk groups, digital anorectal examination, retroflexion, observation, and visualization.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Regularly review endoscopic reports for missed lesions.
- Establish a follow-up protocol for patients diagnosed with anal and anorectal tumors.
Risks
Patient & Prescribing Data
Patients with histologically confirmed anal and anorectal tumors.
Focus on improving endoscopic techniques and training.
Clinical Best Practices
- Implement the IMPROVE detection strategy.
- Enhance endoscopist training on anal and anorectal tumor features.
- Conduct thorough quadrant mapping during endoscopy.
- Encourage interdisciplinary collaboration for improved detection.
References
